BLAC Bellevue Life Sciences Acquisition Corporation

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

Commission File Number: 001-41390

 

(Check one):

 

☐ Form 10-K ☐  Form 20-F ☐  Form 11-K ☒ Form 10-Q ☐  Form 10-D ☐  Form N-CEN

☐ Form N-CSR

 

 

 

 

 

For Period Ended: March 31, 2023

 

 

 

☐   Transition Report on Form 10-K

 

 

☐   Transition Report on Form 20-F

 

 

☐   Transition Report on Form 11-K

 

 

☐   Transition Report on Form 10-Q

 

 

For the Transition Period Ended: _____________

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

Bellevue Life Sciences Acquisition Corp.

Full Name of Registrant

N/A

Former Name if Applicable

10900 NE 4th Street, Suite 2300

Address of Principal Executive Office (Street and Number)

Bellevue, WA 98004

City, State and Zip Code

 (a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

☒

 (b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN, or N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed date; and

 (c)

The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

(1)

Name and telephone number of person to contact in regard to this notification

 

Kuk Hyoun Hwang

 

(425)

 

635-7700

 

(Name)

 

(Area Code)

 

(Telephone Number)

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

 

Yes  ☒ No ☐

  

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

Yes ☐    No ☒

 

 

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

Date: May 16, 2023

By:

 

Name:

     Kuk Hyoun Hwang

 

Title:

     Chief Executive Officer